ロード中...

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations

Down syndrome (DS), also known as trisomy 21, is the most common genetic cause of intellectual disability (ID). Although ID can be mild, the average intelligence quotient is in the range of 40–50. All individuals with DS will also develop the neuropathology of Alzheimer’s disease (AD) by the age of...

詳細記述

保存先:
書誌詳細
出版年:Drug Des Devel Ther
第一著者: Gardiner, Katheleen J
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277121/
https://ncbi.nlm.nih.gov/pubmed/25552901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S51476
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!